PERSONAL FINANCEHow to Evaluate Biotechs That Aren't Profitable YetBy Nadine WongJan 24, 2002 7:50 AM EST
PERSONAL FINANCEThis Earnings Season Could Be a Good One for BiotechsBy Nadine WongJan 17, 2002 7:27 AM EST
PERSONAL FINANCEThe Amgen-Immunex Deal Is the Right PrescriptionBy Nadine WongDec 20, 2001 9:24 AM EST
PERSONAL FINANCEWho Wins, Who Loses in the MedImmune-Aviron DealBy Nadine WongDec 6, 2001 8:02 AM EST
PERSONAL FINANCEHow to Know if the Price Is Right on a Biotech Stock By Nadine WongNov 15, 2001 7:10 AM EST
PERSONAL FINANCEProtein Design Labs' Pipeline Shows Some Promising New Drugs By Nadine WongNov 8, 2001 8:39 AM EST
PERSONAL FINANCECiphergen Ready to Capitalize on New Protein ResearchBy Nadine WongOct 31, 2001 2:43 PM EST
PERSONAL FINANCEThese Bioterrorism Stocks Aren't Worth Playing Anymore By Nadine WongOct 17, 2001 12:43 PM EDT
